← Contracts
PT
Ajuste direto para aquisição de T1140 - TRIPTORRELINA (PÓ P/ SOL INJ) [0.1 MG/ML; 1 ML; FRS] e T202 - TRIPTORRELINA (PÓ P/ SUSP INJ) [3,75MG; FRS/ SERINGA] para suprir necessidades na área da saúde.
ID 11212216
· Portal BASE
Price
Base Price
€27,345
.00
Effective Price
€615
.00
-97.8%
Contract Details
- Contract Type
- Aquisição de bens móveis
- Procedure
- Ajuste Direto Regime Geral
- CPV Code
- 33600000
- Location
- Portugal, Lisboa, Lisboa
- Bidder Count
- —
Winner
IPSEN PORTUGAL - PRODUTOS FARMACEUTICOS S.A.
NIF 502609800
Dates
- Publication
- 06 Feb 2025
- Celebration
- 29 Jan 2025
Contracting Entity
Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE
NIF 506361616
Public body
Data Source
Portal BASE
Api
· synced 2026-04-17
Risk Flags
Score 60 · MEDIUM RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
- Authority
- 86
- Supplier
- 85
- Number of Awards
- 7
- Rule
- A1 repeat direct award: 7 awards within 36 months
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
- Base price
- 27345.0
- Total effective price
- 615.0
- Ratio
- 0.0225
- Direction
- reduction
- Rule
- A9 price reduction: ratio 0.0225 outside [0.5, 1.5]
Detected 2026-03-06